Advances in Circulating Tumor Cells as a Liquid Biopsy for Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 2999
Special Issue Editors
Interests: liquid biopsies; ovarian cancer; melanoma
Interests: liquid biopsies; melanoma; lung cancer
Special Issue Information
Dear Colleagues,
Cancer-related deaths have been attributed to the metastatic spread of tumour cells from the primary lesion to distant organs. As dissemination mostly occurs through the blood, the detection and characterisation of circulating tumour cells (CTCs) have become promising areas of oncology research. In the last decade, studies on CTCs have provided important insights into their role in cancer dissemination and, as one of the pillars constituting “liquid biopsy”, their potential utility as a clinically useful biomarker for timely disease detection, treatment response and disease progression evaluation, elucidation of disease mechanisms, and therapeutic target identification for drug development.
This Special Issue invites experts to contribute original research articles, as well as review articles, that describe the recent advances in CTC research in various cancer types. Potential topics include, but are not limited to, the following:
- New technologies and methods for the isolation and detection of CTCs;
- New approaches to characterise CTC biology;
- Genomics, transcriptomics, proteomics and/or epigenetic profiling of CTCs;
- Latest findings in CTC research and clinical implementation in various cancer types.
Dr. Leslie Calapre
Dr. Aaron Beasley
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- circulating tumor cells
- biology
- liquid biopsy
- cancer
- clinical implementation
